Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Somalogic Inc.
Headquarters: CO, United States of America
Website: N/A
Year Founded: 1999
Status: Acquired
BioCentury | Feb 7, 2025
Management Tracks
Novartis’ Jeffrey Legos becomes chief of oncology at Pfizer
Plus: Tubulis hires Matthew Norkunas as CFO, and Viracta appoints Jalbert to wind down operations
BioCentury | May 16, 2023
Management Tracks
JLABS vet Calcagno becomes CBO of Vir
Plus: Therini names Frank Lee executive chair and updates from OMass, Sapir, Pan Cancer T, and more
BioCentury | Oct 19, 2022
Management Tracks
New chairs at SomaLogic, Anjarium
Plus Dechamps becomes CEO at Bioxodes, and updates from Abalos, M2Gen and Orion
BioCentury | Aug 26, 2022
Discovery & Translation
Detecting Parkinson’s via breathing signals; plus Antisense, Noster and more
BioCentury’s roundup of translational news
BioCentury | Apr 9, 2022
Discovery & Translation
SomaLogic’s cardiovascular risk surrogate; plus SQZ, Alpine and more
BioCentury’s roundup of translational news
BioCentury | Jan 12, 2022
Management Tracks
Alector’s Robert Paul becomes CEO at Nine Square
Plus Smeal joins Cardiff as CSO and updates from GHIT, Aclaris, Iovance, Pyramid, SomaLogic and more
BioCentury | Dec 4, 2021
Management Tracks
Aubuchon becomes CCO at AbCellera
Plus: Albireo, Fore, Code, SomaLogic and more
BioCentury | Dec 3, 2021
Discovery & Translation
Mapping the plasma proteome to identify drug targets; plus GSK-Vir, Codiak and more
BioCentury’s roundup of translational news
BioCentury | Aug 4, 2021
Management Tracks
Qian joins LianBio as general manager of China
Hoffman out as Zymergen CEO, plus updates from Scholar Rock, Ironwood, Keros, Madrigal and more
BioCentury | Mar 30, 2021
Deals
March 29 Quick Takes: SPAC carrying SomaLogic to NASDAQ; plus LianBio-Tarsus, Qihan, Biohaven, Tempest
SomaLogic Inc. is merging with CM Life Sciences II, a SPAC sponsored by Casdin Capital and Corvex Management (NASDAQ:CMIIU). The deal is expected to give the proteomics company up to $651 million
Items per page:
1 - 10 of 54